SKU/Artículo: AMZ-0998407526

The Pharmagellan Guide to Analyzing Biotech Clinical Trials

Format:

Paperback

Kindle

Paperback

Detalles del producto
Disponibilidad:
En stock
Peso con empaque:
1.05 kg
Devolución:
Condición
Nuevo
Producto de:
Amazon
Viaja desde
USA

Sobre este producto
  • ** Get info on bulk orders & how to get a free chapter at https://www.pharmagellan.com/books ** If you work in or around biotech, you’re supposed to understand clinical trial results. But what if you’re not an expert in study design or biostatistics? You may feel out of your comfort zone when faced with a journal article, press release, or investor presentation. The Pharmagellan Guide to Analyzing Biotech Clinical Trials is a comprehensive primer to help non-experts evaluate clinical studies of new therapies.Structured roadmap for assessing the main components of a planned or completed biotech trial.Clear explanations of the most common concepts and terms in clinical studies, illustrated with over 100 real-world examples.Deep dives on essential topics like P values, sample size calculations, and Kaplan-Meier curves, written in plain English for non-statisticians.Pointers for interpreting positive and negative results, understanding common figures and tables, and identifying red flags in press releases. If you're a biotech executive, investor, adviser, or entrepreneur -- or aspire to be one -- this handbook will give you the foundation you need to analyze clinical trials with more confidence.
U$S 59,00
5% OFF
U$S 56,05

IMPORTÁ FACIL

Comprando este producto podrás descontar el IVA con tu número de RUT

NO CONSUME FRANQUICIA

Si tu carrito tiene solo libros o CD’s, no consume franquicia y podés comprar hasta U$S 1000 al año.

U$S 59,00
5% OFF
U$S 56,05

¡Comprá en hasta 12 cuotas sin interés con todas tus tarjetas!

Llega en 5 a 11 días hábiles
con envío
Tienes garantía de entrega
Este producto viaja de USA a tus manos en